2 Day: Nov. 15-16
4 Day: Nov 15-18
Abstract Submission Opens April 16
Registration Begins in June!
Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation
Late-Breaking Abstracts in Resuscitation Science at ReSS
These innovative abstracts will provide the latest breakthroughs in basic and clinical science, presenting cutting-edge, exciting and pivotal research results. Posters will be presented on Saturday evening, and Orals will be presented on Sunday afternoon.
ReSS Session XIV, State of the Science - Hypothermia, 2:15 - 3:30 PM at the Omni Dallas Hotel.
This session will include a panel of hypothermia experts who will summarize the state-of-the-science related to hypothermia. ReSS will adjourn after this session to allow participants to attend the late- breaking clinical trial session being held in the Dallas Convention Center.
Scientific Sessions Late Breaking Clinical Trials LBCT.01, Acute Cardiovascular and Cerebrovascular Care, 4:00 - 5:19 PM in Hall E of the Dallas Convention Center.
ReSS attendees are invited to attend this session at no additional cost. These hypothermia clinical trials will be presented in this session:
- Randomized Clinical Trial of Pre-hospital Induction of Mild Hypothermia in Out-of-Hospital Cardiac Arrest Patients Using a Rapid Infusion of 4oC Normal Saline - The aims of this randomized clinical trial were to determine whether early in-field cooling improves survival, functional status in resuscitated cardiac arrest patients.
- Target Temperature Management 33°C Versus 36°C After Out-of-hospital Cardiac Arrest, A Randomized, Parallel Group, Assessor Blinded Clinical Trial: TTM - This randomized trial was designed to investigate the optimal target temperature management strategy after out-of-hospital cardiac arrest with regard to survival, neurological function and safety.
To see the other abstracts being presented at ReSS, visit the Program Planner.
Abstracts and presentations are embargoed for release at date and time of presentation or time of AHA news event. Written embargoed information cannot be shared with anyone but one-on-one embargoed media interviews can be conducted as long as the reporter agrees to abide by the embargo policy. Failure to honor embargo policies will result in the abstract being withdrawn and barred from presentation. View the complete AHA/ASA General Embargo Policies.